10x Genomics, Inc. (TXG) Revenue by Year

TXG

10x Genomics, Inc. generated $642.8M in revenue in fiscal year 2025. This represents an increase of 5.2% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $616.9M in revenue. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters 10x Genomics, Inc. has filed alongside them.

FY2025 annual

Revenue $642.8M

YoY +5.2%

5Y CAGR +16.6%

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 7, 2026 Currency USD

Annual figures, oldest first. Point at a bar to read its period.

TXG Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K
Revenue	$616.9M	$642.8M+5.2%	$610.8M-1.3%	$618.7M+19.8%	$516.4M+5.3%	$490.5M+64.1%	$298.8M+21.5%	$245.9M+68.1%	$146.3M+105.8%	$71.1M

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

TXG Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-K	Q3'2310-Q
Revenue	$151.0M-12.6%	$150.8M-2.6%	$166.0M+0.6%	$149.0M-1.7%	$172.9M+12.9%	$154.9M+9.8%	$165.0M-10.3%	$151.7M-1.3%	$153.1M+4.3%	$141.0M+5.0%	$184.0M+17.8%	$153.6M+17.2%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More 10x Genomics, Inc. financials

Frequently Asked Questions

What was 10x Genomics, Inc.'s revenue in fiscal year 2025?

10x Genomics, Inc. generated $642.8M in revenue in fiscal year 2025.

How fast is 10x Genomics, Inc.'s revenue growing?

10x Genomics, Inc. (TXG) revenue rose by 5.2% year over year, from $610.8M to $642.8M in fiscal year 2025.

What is 10x Genomics, Inc.'s revenue over the last twelve months?

10x Genomics, Inc. (TXG) reported $616.9M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

How has 10x Genomics, Inc.'s revenue changed over the years?

Across the 9 fiscal years this page covers, 10x Genomics, Inc. (TXG) revenue went from $71.1M in fiscal year 2017 to $642.8M in fiscal year 2025.

What was 10x Genomics, Inc.'s revenue in the most recent quarter?

10x Genomics, Inc. (TXG) reported $151.0M in revenue in Q2 2026. This represents a decrease of 12.6% from the same quarter a year earlier.

What does revenue mean on a financial statement?

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what 10x Genomics, Inc. (TXG) reported on that line in every period on record.